Clinical Trial Update: Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial reporting on the efficacy and safety of everolimus versus mycophenolate mofetil in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Afinitor (everolimus)
• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Liver Transplant | Phase 4 | Status: COMPLETED